Publications

Title

Author

Year

VALIDATE: Exploiting the synergy between complex intracellular pathogens to expedite vaccine research and development for tuberculosis, leishmaniasis, melioidosis and leprosy.

FLETCHER, HA; Chatterjee, M; Cooper, A; Hussell, T; Kaye, PM; Prior, J; Reljic, R; Vermaak, S; Vordermeier, M; Williams, A; McShane, H;

2018

F1000Research, (2018).7, 10.12688/f1000research.14386.1.

Author Correction: Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis.

COLL, F; PHELAN, J; Hill-Cawthorne, GA; Nair, MB; Mallard, K; Ali, S; Abdallah, AM; Alghamdi, S; Alsomali, M; Ahmed, AO; Portelli, S; OPPONG, Y; Alves, A; Bessa, TB; CAMPINO, S; Caws, M; Chatterjee, A; CRAMPIN, AC; DHEDA, K; FURNHAM, N; GLYNN, JR; Grandjean, L; Ha, DM; Hasan, R; Hasan, Z; ... CLARK, TG.

2018

Nature genetics, (2018).50 5 10.1038/s41588-018-0074-3.

Attrition when providing antiretroviral treatment at CD4 counts >500cells/μL at three government clinics included in the HPTN 071 (PopART) trial in South Africa.

Bock, P; Fatti, G; Ford, N; Jennings, K; Kruger, J; Gunst, C; Louis, F; Grobbelaar, N; Shanaube, K; FLOYD, S; Grimwood, A; HAYES, R; AYLES, H; Fidler, S; Beyers, N; HPTN 071 (PopART) trial team,;

2018

PloS one, (2018).13 4 10.1371/journal.pone.0195127.

Evaluating UK National Guidance for Screening of Children for Tuberculosis. A Prospective Multicenter Study.

KAMPMANN, B; Seddon, JA; Paton, J; Nademi, Z; Keane, D; Williams, B; Williams, A; Liebeschutz, S; Riddell, A; Bernatoniene, J; Patel, S; Martinez, N; McMaster, P; Basu-Roy, R; Welch, SB;

2018

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, (2018).197 8 10.1164/rccm.201707-1487OC.

A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household Contacts.

Duffy, FJ; Thompson, E; Downing, K; Suliman, S; Mayanja-Kizza, H; Boom, WH; Thiel, B; Weiner Iii, J; Kaufmann, SH E; Dover, D; Tabb, DL; DOCKRELL, HM; Ottenhoff, TH M; Tromp, G; Scriba, TJ; Zak, DE; Walzl, G; GC6-74 Consortium,;

2018

Frontiers in immunology, (2018).9 APR 10.3389/fimmu.2018.00661.

Small contribution of gold mines to the ongoing tuberculosis epidemic in South Africa: a modeling-based study.

Chang, ST; Chihota, VN; FIELDING, KL; GRANT, AD; HOUBEN, RM; WHITE, RG; CHURCHYARD, GJ; Eckhoff, PA; Wagner, BG;

2018

BMC medicine, (2018).16 1 10.1186/s12916-018-1037-3.

High use of private providers for first healthcare seeking by drug-resistant tuberculosis patients: a cross-sectional study in Yangon, Myanmar.

Sidharta, SD; Yin, JD-C; Yoong, JS-Y; KHAN, MS;

2018

BMC health services research, (2018).18 1 10.1186/s12913-018-3077-y.

Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014.

Cornejo Garcia, JG; Alarcón Guizado, VA; Mendoza Ticona, A; Alarcon, E; Heldal, E; MOORE, DA J;

2018

PloS one, (2018).13 12 10.1371/journal.pone.0206658.

A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study.

Walker, TM; Merker, M; Knoblauch, AM; Helbling, P; Schoch, OD; Van der Werf, MJ; KRANZER, K; Fiebig, L; Kröger, S; Haas, W; Hoffmann, H; Indra, A; Egli, A; Cirillo, DM; Robert, J; Rogers, TR; Groenheit, R; Mengshoel, AT; Mathys, V; Haanperä, M; Soolingen, DV; Niemann, S; Böttger, EC; Keller, PM; MDR-TB Cluster Consortium,;

2018

LANCET INFECTIOUS DISEASES, (2018).18 4 10.1016/S1473-3099(18)30004-5.

Tuberculosis transmission during the subclinical period: could unrelated cough play a part?.

Esmail, H; Dodd, PJ; HOUBEN, RM G J;

2018

The lancet Respiratory medicine, (2018).6 4 10.1016/S2213-2600(18)30105-X.